Liver International

Cover image for Vol. 29 Issue 2

February 2009

Volume 29, Issue 2

Pages 143–318

  1. Editorials

    1. Top of page
    2. Editorials
    3. Clinical Studies
    4. Live International Image
    5. Basic Studies
    6. Letters to the Editor
  2. Clinical Studies

    1. Top of page
    2. Editorials
    3. Clinical Studies
    4. Live International Image
    5. Basic Studies
    6. Letters to the Editor
    1. A multicenter retrospective cohort study of practice patterns and clinical outcome on radiotherapy for hepatocellular carcinoma in Korea (pages 147–152)

      Jinsil Seong, Ik Jae Lee, Su Jung Shim, Do Hoon Lim, Tae Hyun Kim, Jong Hoon Kim, Hong Seok Jang, Mi Sook Kim, Eui Kyu Chie, Jin Hee Kim, Taek-Keun Nam, Hyung Sik Lee and Chul Joo Han

      Version of Record online: 15 SEP 2008 | DOI: 10.1111/j.1478-3231.2008.01873.x

    2. Effect of steatosis and inflammation on liver fibrosis in chronic hepatitis C (pages 153–158)

      Urpo Nieminen, Perttu E. T. Arkkila, Päivi Kärkkäinen and Martti A. Färkkilä

      Version of Record online: 15 MAY 2008 | DOI: 10.1111/j.1478-3231.2008.01779.x

    3. Non-alcoholic fatty liver disease prevalence among school-aged children and adolescents in Iran and its association with biochemical and anthropometric measures (pages 159–163)

      Seyed-Moayed Alavian, Amir-Hooshang Mohammad-Alizadeh, Farzaneh Esna-Ashari, Gelayol Ardalan and Behzad Hajarizadeh

      Version of Record online: 19 MAY 2008 | DOI: 10.1111/j.1478-3231.2008.01790.x

    4. Association between combinations of glutathione-S-transferase M1, T1 and P1 genotypes and non-alcoholic fatty liver disease (pages 164–168)

      Masaharu Hori, Kentaro Oniki, Takehiro Nakagawa, Keiji Takata, Shuichi Mihara, Toru Marubayashi and Kazuko Nakagawa

      Version of Record online: 20 MAY 2008 | DOI: 10.1111/j.1478-3231.2008.01794.x

    5. The effect  of  1  month  of  therapy with midodrine, octreotide-LAR and albumin in refractory ascites: a pilot study (pages 169–174)

      Puneeta Tandon, Ross T. Tsuyuki, Lesley Mitchell, Michael Hoskinson, Mang M. Ma, Winnie W. Wong, Andrew L. Mason, Klaus Gutfreund and Vincent G. Bain

      Version of Record online: 20 MAY 2008 | DOI: 10.1111/j.1478-3231.2008.01778.x

    6. Morbidity and mortality after liver resection for benign and malignant hepatobiliary lesions (pages 175–180)

      Deha Erdogan, Olivier R. C. Busch, Dirk J. Gouma and Thomas M. Van Gulik

      Version of Record online: 28 JUN 2008 | DOI: 10.1111/j.1478-3231.2008.01806.x

    7. New aspects of liver abnormalities as part of the systemic mast cell activation syndrome (pages 181–186)

      Kirsten Alfter, Ivar Von Kügelgen, Britta Haenisch, Thomas Frieling, Alexandra Hülsdonk, Ulrike Haars, Arndt Rolfs, Gerhard Noe, Ulrich W. Kolck, Jürgen Homann and Gerhard J. Molderings

      Version of Record online: 25 JUL 2008 | DOI: 10.1111/j.1478-3231.2008.01839.x

    8. Gender-incompatible liver transplantation is not a risk factor for patient survival (pages 196–202)

      Frank Lehner, Thomas Becker, Jürgen Klempnauer and Jürgen Borlak

      Version of Record online: 30 JUL 2008 | DOI: 10.1111/j.1478-3231.2008.01827.x

    9. Syndecan 1 (CD138) serum levels: a novel biomarker in predicting liver fibrosis stage in patients with hepatitis C (pages 208–212)

      Isabel Zvibel, Phillipe Halfon, Sigal Fishman, Guillaume Penaranda, Moshe Leshno, Anat Bet Or, Zamir Halpern and Ran Oren

      Version of Record online: 8 AUG 2008 | DOI: 10.1111/j.1478-3231.2008.01830.x

    10. Hepatitis C virus infection enhances insulin resistance induced by visceral fat accumulation (pages 213–220)

      Yuichiro Eguchi, Toshihiko Mizuta, Eriko Ishibashi, Yoichiro Kitajima, Noriko Oza, Shunya Nakashita, Megumi Hara, Shinji Iwane, Hirokazu Takahashi, Takumi Akiyama, Keisuke Ario, Yasunori Kawaguchi, Tsutomu Yasutake, Ryuichi Iwakiri, Iwata Ozaki, Akitaka Hisatomi, Takahisa Eguchi, Naofumi Ono and Kazuma Fujimoto

      Version of Record online: 15 AUG 2008 | DOI: 10.1111/j.1478-3231.2008.01853.x

    11. Model for end-stage liver disease, model for end-stage liver disease-sodium and Child–Turcotte–Pugh scores over time for the prediction of complications of liver cirrhosis (pages 221–226)

      Pil Cho Choi, Hong Joo Kim, Woo Hyuk Choi, Dong Il Park, Jung Ho Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon and Byung Ik Kim

      Version of Record online: 9 JUN 2008 | DOI: 10.1111/j.1478-3231.2008.01803.x

    12. Prevalence and virological features of occult hepatitis B virus infection in female sex workers who work uncontrolled in Turkey (pages 227–230)

      Binnur Pinarbasi, Derya Onel, Fulya Cosan, Filiz Akyuz, Nezihe Dirlik, Yilmaz Cakaloglu, Selim Badur, Fatih Besisik, Kadir Demir, Atilla Okten and Sabahattin Kaymakoglu

      Version of Record online: 25 JUL 2008 | DOI: 10.1111/j.1478-3231.2008.01809.x

    13. Pretreatment alanine transaminase level may not be the most important predictor of HBeAg loss in the older patient (pages 231–236)

      Jung Il Lee, Hyun Joo Park, Jin Woo Lee, Young Soo Kim, Seok Jeong, Don Haeng Lee, Hyung Gil Kim, Yong Woon Shin and Kye Sook Kwon

      Version of Record online: 10 JUL 2008 | DOI: 10.1111/j.1478-3231.2008.01815.x

    14. Hepatic steatosis in patients with chronic hepatitis C virus genotype 2 or 3 does not affect viral response in patients treated with peginterferon α-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) for 16 or 24 weeks (pages 237–241)

      Maribel Rodriguez-Torres, Sugantha Govindarajan, Moises Diago, Thomas Morgan, Bhupinderjit Anand, Karl Barange, Frank Suter, Amy Lin, Gregory Hooper and Mitchell Shiffman

      Version of Record online: 15 AUG 2008 | DOI: 10.1111/j.1478-3231.2008.01859.x

    15. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B (pages 242–247)

      Patrick Marcellin, Marianne Ziol, Pierre Bedossa, Catherine Douvin, Raoul Poupon, Victor De Lédinghen and Michel Beaugrand

      Version of Record online: 10 JUL 2008 | DOI: 10.1111/j.1478-3231.2008.01802.x

    16. Homocysteine levels and sustained virological response to pegylated-interferon α2b plus ribavirin therapy for chronic hepatitis C: a prospective study (pages 248–252)

      Guglielmo Borgia, Ivan Gentile, Giuliana Fortunato, Francesco Borrelli, Salvatore Borelli, Maurizio De Caterina, Maria Donata Di Taranto, Maria Simone, Federico Borgia, Chiara Viola, Laura Reynaud, Raimondo Cerini and Lucia Sacchetti

      Version of Record online: 25 JUL 2008 | DOI: 10.1111/j.1478-3231.2008.01832.x

    17. Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival – an 18-year experience (pages 253–259)

      Rupesh Rajani, Tor Melin, Einar Björnsson, Ulrika Broomé, Per Sangfelt, Åke Danielsson, Anders Gustavsson, Olof Grip, Hans Svensson, Lars Lööf, Sven Wallerstedt and Sven HC Almer

      Version of Record online: 8 AUG 2008 | DOI: 10.1111/j.1478-3231.2008.01838.x

    18. Neuropsychological impairment in severe acute viral hepatitis is due to minimal hepatic encephalopathy (pages 260–264)

      Praveen Sharma, Barjesh Chander Sharma, Pankaj Tyagi, Manoj Kumar and Shiv Kumar Sarin

      Version of Record online: 15 AUG 2008 | DOI: 10.1111/j.1478-3231.2008.01856.x

  3. Live International Image

    1. Top of page
    2. Editorials
    3. Clinical Studies
    4. Live International Image
    5. Basic Studies
    6. Letters to the Editor
    1. Anaphylactic shock in a young woman with abnormal liver scans (page 265)

      Joerg C. Henes, Martin Heuschmid, Michael Haap and Reimer Riessen

      Version of Record online: 1 OCT 2008 | DOI: 10.1111/j.1478-3231.2008.01886.x

  4. Basic Studies

    1. Top of page
    2. Editorials
    3. Clinical Studies
    4. Live International Image
    5. Basic Studies
    6. Letters to the Editor
    1. Caveolin-1 and Rac regulate endothelial capillary-like tubular formation and fenestral contraction in sinusoidal endothelial cells (pages 266–276)

      Hiroaki Yokomori, Masaya Oda, Kazunori Yoshimura, Toshihiro Nagai, Kayo Fujimaki, Shuichi Watanabe and Toshifumi Hibi

      Version of Record online: 4 DEC 2008 | DOI: 10.1111/j.1478-3231.2008.01891.x

    2. Upregulation of indoleamine 2,3-dioxygenase in hepatocyte during acute hepatitis caused by hepatitis B virus-specific cytotoxic T lymphocytes in vivo (pages 277–283)

      Naoki Iwamoto, Hiroyasu Ito, Kazuki Ando, Tetsuya Ishikawa, Akira Hara, Ayako Taguchi, Kuniaki Saito, Masao Takemura, Michio Imawari, Hisataka Moriwaki and Mitsuru Seishima

      Version of Record online: 7 APR 2008 | DOI: 10.1111/j.1478-3231.2008.01748.x

    3. Phosphorylation of extracellular signal-regulated kinase 1/2, p38 mitogen-activated protein kinase and nuclear translocation of nuclear factor-κB are involved in upregulation of matrix metalloproteinase-9 by tumour necrosis factor-α (pages 291–298)

      Keita Itatsu, Motoko Sasaki, Kenichi Harada, Junpei Yamaguchi, Hiroko Ikeda, Yasunori Sato, Tetsuo Ohta, Hiroshi Sato, Masato Nagino, Yuji Nimura and Yasuni Nakanuma

      Version of Record online: 15 AUG 2008 | DOI: 10.1111/j.1478-3231.2008.01858.x

    4. Activated protein C prevents hepatic ischaemia–reperfusion injury in rats (pages 299–307)

      Naohisa Kuriyama, Shuji Isaji, Takashi Hamada, Masashi Kishiwada, Ichiro Ohsawa, Masanobu Usui, Hiroyuki Sakurai, Masami Tabata, Koji Suzuki and Shinji Uemoto

      Version of Record online: 27 MAY 2008 | DOI: 10.1111/j.1478-3231.2008.01796.x

    5. Antifibrogenic effects of tamoxifen in a rat model of periportal hepatic fibrosis (pages 308–314)

      Soo Hyung Ryu, Young-Hwa Chung, Jae Kyun Lee, Jeong A. Kim, Jung Woo Shin, Myoung Kuk Jang, Neung Hwa Park, Han Chu Lee, Yung Sang Lee and Dong Jin Suh

      Version of Record online: 28 JUN 2008 | DOI: 10.1111/j.1478-3231.2008.01811.x

  5. Letters to the Editor

    1. Top of page
    2. Editorials
    3. Clinical Studies
    4. Live International Image
    5. Basic Studies
    6. Letters to the Editor
    1. Bilirubin concentration and cardiovascular risk profile (pages 315–316)

      Giuseppe Lippi, Giovanni Targher, Martina Montagnana, Gian Luca Salvagno and Gian Cesare Guidi

      Version of Record online: 24 JUL 2008 | DOI: 10.1111/j.1478-3231.2008.01821.x

SEARCH

SEARCH BY CITATION